Cargando…
非小细胞肺癌治疗的新靶点:EML4-ALK融合基因
It was only 3 years ago that the fusion gene between echinoderm microtubule-associated protein-like4 (EML4) and anaplastic lymphoma kinase (ALK) has been identified in a subset of non-small cell lung cancer (NSCLC). EML4-ALK is most often detected in never smokers with lung adenocarcinoma and has un...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999890/ https://www.ncbi.nlm.nih.gov/pubmed/21645460 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.06.11 |
Ejemplares similares
-
EML4-ALK融合基因在非小细胞肺癌中的临床意义
Publicado: (2013) -
非小细胞肺癌靶向治疗的靶点研究进展
Publicado: (2013) -
非小细胞肺癌中EML4-ALK融合及临床治疗进展
Publicado: (2011) -
晚期非小细胞肺癌ALK融合基因及其他少见驱动基因阳性靶向治疗进展
Publicado: (2017) -
ALK融合基因阳性非小细胞肺癌的研究进展
Publicado: (2018)